Stay connected with updated news and Kure It event highlights
Here's what is happening with Kure It and our Research Partners
Kure It Cancer Research Awards 2023 Barry Hoeven Memorial Grant
Newport Beach, CA, December 31, 2023 – In a move to drive innovation and advancement in
cancer research, Kure It Cancer Research (Kure It) proudly announces the selection of Dr. Pedro
Barata as this year’s recipient of the prestigious Barry Hoeven Memorial Kidney Cancer Research.
Project Grant.
Kure It Grants $250K to Selected 2023 Cancer Research Projects
Kure It Cancer Research (Kure It) announced that two researchers from the University of California San Diego and City of Hope will be receiving grants for their research proposals for kidney and bile duct cancers.
Cell-free DNA methylation used to predict chemo benefit in bladder cancer
A team of researchers from SWOG Cancer Research Network, a cancer clinical trials group funded by the National Cancer Institute (NCI), have shown that they can use methylation patterns in cell-free DNA (cfDNA) extracted from blood samples to predict which patients with muscle-invasive bladder cancer are likely to benefit from chemotherapy before their surgery.
$200,000 Grant to support Haake’s research on kidney cancer
Kure It Cancer Research has awarded a $200,000 grant to support the work of Scott Haake, MD, assistant professor of Medicine in the Division of Hematology and Oncology.
Haake’s research involves how RNA sequence-based biomarkers can identify targetable biologic drivers of kidney cancer. Kure it Inc. is a nonprofit that funds translational research projects focused on kidney cancer and other underfunded cancers.
